Ozempic reduces knee osteoarthritis pain by almost half

Can Ozempic and Wegovy help reduce knee osteoarthritis-related pain?
Westend61/Getty Images The use of GLP-1 medications such as semaglutide — more widely known under the brand names of Ozempic and Wegovy — have greatly increased over the last few years. There has also been an increase in research examining other ...
Ozempic, Wegovy might help ease knee arthritis pain
People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after 68 weeks, compared with 3% of people given a placebo, results showed. The trial was funded by Novo Nordisk, the drug company that makes semaglutide.
Can Ozempic Treat Arthritis Related Knee-Pain ? New Study Say Yes
Recent research has found that semaglutide injections, which also include controversial weight loss drug Ozempic, can reduce knee pain caused by obesity-related arthritis.
Ozempic reduces knee osteoarthritis pain by almost half: Study
The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain
Ozempic, Wegovy may help ease knee pain
A new study has found that weight loss drugs Ozempic and Wegovy have another proven benefit. Emory University's Dr. Neil Winawer sits down with Alyse Eady to examine the study's findings.

Novo Nordisk posts Q3 sales of obesity drug Wegovy

Ozempic, Wegovy ingredient may lower risk of Alzheimer’s, study finds
Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health ...
Scientist behind Novo Nordisk's Ozempic, Wegovy started her career developing laundry detergent
Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...
FiercePharma15h
After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy
Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...
Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand
On Wednesday, Novo Nordisk A/S (NYSE:NVO) reported third-quarter 2024 sales of 71.311 billion Danish kroner (around $10.3 ...
Ozempic and Wegovy considered ‘available’ after more than 2 years in shortage
The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...
How a love story launched the company behind Ozempic, Wegovy
Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...
Ozempic, Wegovy move closer to no longer being in shortage, FDA says
Both Ozempic and Mounjaro are approved by the FDA to treat Type 2 diabetes, but some doctors prescribe the medication ...
Investor's Business Daily on MSN13h
Novo Nordisk Dips After Tightening Its Outlook As Wegovy Beats, But Ozempic Misses
Novo Nordisk stock inched down Wednesday after the drugmaker's weight-loss drug beat forecasts, but sales of its diabetes behemoth missed.
STAT7d
Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA
Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...